{"id":1931,"date":"2022-04-27T15:54:00","date_gmt":"2022-04-27T14:54:00","guid":{"rendered":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/?p=1931"},"modified":"2026-01-26T15:02:33","modified_gmt":"2026-01-26T15:02:33","slug":"alessio-talks-to-sofia-rodriguez-on-beacon-brainstorm-on-drug-design-and-the-future-of-tpd","status":"publish","type":"post","link":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/2022\/04\/27\/alessio-talks-to-sofia-rodriguez-on-beacon-brainstorm-on-drug-design-and-the-future-of-tpd\/","title":{"rendered":"Alessio talks to Sofia Rodriguez on Beacon Brainstorm on Drug Design and the Future of TPD"},"content":{"rendered":"<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"650\" height=\"300\" src=\"https:\/\/sites.dundee.ac.uk\/wp-content\/uploads\/sites\/233\/2023\/12\/Beacon-Brainstorm-TPD-podcast.jpg\" alt=\"Poster of Beacon Brainstorm TPD podcast with photos of Sofia Rodriguez and Alessio Ciulli\" style=\"width:617px;height:auto\"><\/figure>\n<\/p>\n<p>Targeted protein degradation (TPD) is an innovative field that is revolutionising drug development, with various modalities being explored by researchers to tackle undruggable targets and treat a wide range of diseases, including cancer, neurological disorders, and skin diseases.<\/p>\n<p>In this episode, Sofia Rodriguez talks to Alessio Ciulli, professor of chemical structural biology at the University of Dundee and co-founder of Amphista Therapeutics, the leading Europe-based TPD company. Join us to hear about his lab\u2019s ground-breaking research into protein degradation, the opening of the new Centre for Targeted Protein Degradation (CeTPD), and the opportunities and challenges of novel degrader design.<\/p>\n<p>Listen to it here:\u00a0<a href=\"https:\/\/ter.li\/f7x0yq\">https:\/\/ter.li\/f7x0yq<\/a><\/p>\n<p>Beacon is delighted to announce the launch of\u00a0<strong>our very own podcast series \u2013<\/strong>\u00a0<strong>Beacon Brainstorms<\/strong>.<\/p>\n<p>In episode 1 our TPD analyst, Sofia Rodriguez,\u00a0interviewed\u00a0Alessio Ciulli \u2013 Professor of chemical structural biology at the University of Dundee and co-founder of Amphista Therapeutics. Topics of discussion include:\u00a0ground-breaking research being conducted in Dundee, the opening of the university\u2019s new Centre for Targeted Protein Degradation (CeTPD), and the opportunities and challenges of novel degrader design.\u00a0<\/p>\n<p><strong>Be sure to subscribe to stay notified of future episode releases\u00a0<\/strong>where\u00a0the Beacon research team speak to key industry players across various life sciences areas on pressing subjects and key topics.<strong>\u00a0If you would like to join us as a guest speaker, please email us at\u00a0<a href=\"mailto:beacon.marketing@hansonwade.com?subject=Beacon%20Brainstorms%20-%20Guest%20Speaker%20Submission\">beacon.marketing@hansonwade.com<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Targeted protein degradation (TPD) is an innovative field that is revolutionising drug development, with various modalities being explored by researchers to tackle undruggable targets and treat a wide range of diseases, including cancer, neurological disorders, and skin diseases. In this episode, Sofia Rodriguez talks to Alessio Ciulli, professor of chemical structural biology at the University [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13,4],"tags":[],"class_list":["post-1931","post","type-post","status-publish","format-standard","hentry","category-13","category-news"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/wp-json\/wp\/v2\/posts\/1931","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/wp-json\/wp\/v2\/comments?post=1931"}],"version-history":[{"count":1,"href":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/wp-json\/wp\/v2\/posts\/1931\/revisions"}],"predecessor-version":[{"id":4711,"href":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/wp-json\/wp\/v2\/posts\/1931\/revisions\/4711"}],"wp:attachment":[{"href":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/wp-json\/wp\/v2\/media?parent=1931"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/wp-json\/wp\/v2\/categories?post=1931"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/wp-json\/wp\/v2\/tags?post=1931"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}